Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
APOL1-Mediated Kidney Disease and the Emerging Era of Precision Therapy.
Journal: Annual review of medicine
Published: July 21, 2026
Hybrid Community-Electronic Health Record Approaches to Apolipoprotein L1 Kidney Disease Screening and Clinical Trials among Black Individuals.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 30, 2025
A Human Glomerular Disease Atlas defines the APOL1-JAK-STAT feed forward loop in focal segmental glomerulosclerosis.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Prevalence and Impact of APOL1 Kidney Risk Variants in West Africa : Insights for Global Kidney Disease Assessment and Treatment.
Journal: Journal of the American Society of Nephrology : JASN
Published: November 27, 2024
Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 26, 2024
Has APOL1 kidney disease treatment been hiding in plain sight?
Journal: Kidney international
Published: August 14, 2024
Should We Systematically Screen for the Amyloidogenic V142I Variant?
Journal: Journal of cardiac failure
Published: June 09, 2024
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE).
Journal: Kidney international reports
Published: May 12, 2024
APOL1 High-Risk Genotype is Not Associated With New or Worsening of Proteinuria or Kidney Function Decline Following COVID-19 Vaccination.
Journal: Kidney international reports
Published: September 15, 2023
Last Updated: 09/26/2026